|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu PK, Chen WM, Chen CF, Lee OK, Haung CK
and Chen TH: Primary osteogenic sarcoma with pulmonary metastasis:
Clinical results and prognostic factors in 91 patients. Jpn J Clin
Oncol. 39:514–522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han YP, Tuan TL, Wu H, Hughes M and Garner
WL: TNF-alpha stimulates activation of pro-MMP2 in human skin
through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci.
114:131–139. 2001.
|
|
4
|
Séguin CA, Pilliar RM, Madri JA and Kandel
RA: TNF-alpha induces MMP2 gelatinase activity and MT1-MMP
expression in an in vitro model of nucleus pulposus tissue
degeneration. Spine. 33:356–365. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qi S, Xin Y, Guo Y, Diao Y, Kou X, Luo L
and Yin Z: Ampelopsin reduces endotoxic inflammation via repressing
ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int
Immunopharmacol. 12:278–287. 2012. View Article : Google Scholar
|
|
6
|
Zhou WM, He RR, Ye JT, Zhang N and Liu DY:
Synthesis and biological evaluation of new
5-fluorouracil-substituted ampelopsin derivatives. Molecules.
15:2114–2123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murakami T, Miyakoshi M, Araho D, Mizutani
K, Kambara T, Ikeda T, Chou WH, Inukai M, Takenaka A and Igarashi
K: Hepatoprotective activity of tocha, the stems and leaves of
Ampelopsis grossedentata, and ampelopsin. Biofactors. 21:175–178.
2004. View Article : Google Scholar
|
|
8
|
Sayama K, Lin S, Zheng G and Oguni I:
Effects of green tea on growth, food utilization and lipid
metabolism in mice. In Vivo. 14:481–484. 2000.PubMed/NCBI
|
|
9
|
Ni F, Gong Y, Li L, Abdolmaleky HM and
Zhou JR: Flavonoid ampelopsin inhibits the growth and metastasis of
prostate cancer in vitro and in mice. PLoS One. 7:388022012.
View Article : Google Scholar
|
|
10
|
Liu T, Liu P, Ding F, Yu N, Li S, Wang S,
Zhang X, Sun X, Chen Y, Wang F, et al: Ampelopsin reduces the
migration and invasion of ovarian cancer cells via inhibition of
epithelial-to-mesenchymal transition. Oncol Rep. 33:861–867.
2015.
|
|
11
|
Zhou Y, Liang X, Chang H, Shu F, Wu Y,
Zhang T, Fu Y, Zhang Q, Zhu JD and Mi M: Ampelopsin-induced
autophagy protects breast cancer cells from apoptosis through
Akt-mTOR pathway via endoplasmic reticulum stress. Cancer Sci.
105:1279–1287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsai TT, Ho NY, Lin YT, Lai PL, Fu TS, Niu
CC, Chen LH, Chen WJ and Pang JH: Advanced glycation end products
in degenerative nucleus pulposus with diabetes. J Orthop Res.
32:238–244. 2014. View Article : Google Scholar
|
|
13
|
Ren P, Sun D, Xin D, Ma W, Chen P, Gao H,
Zhang S and Gong M: Serum amyloid A promotes osteosarcoma invasion
via upregulating αvβ3 integrin. Mol Med Rep. 10:3106–3112.
2014.PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Bjørnland K, Flatmark K, Pettersen S,
Aaasen AO, Fodstad O and Maelandsmo GM: Matrix metalloproteinases
participate in osteosarcoma invasion. J Surg Res. 127:151–156.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng YC, Kuo WW, Wu HC, Lai TY, Wu CH,
Hwang JM, Wang WH, Tsai FJ, Yang JJ, Huang CY and Chu CH: ZAK
induces MMP-2 activity via JNK/p38 signals and reduces MMP-9
activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast
cells. Mol Cell Biochem. 325:69–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong J, Gencay MM, Bubendorf L, Burgess
JK, Parson H, Robinson BW, Tamm M, Black JL and Roth M: ERK1/2 and
p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect
cell migration: A comparison between mesothelioma and mesothelial
cells. J Cell Physiol. 207:540–552. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schram K, De Girolamo S, Madani S, Munoz
D, Thong F and Sweeney G: Leptin regulates MMP-2, TIMP-1 and
collagen synthesis via p38 MAPK in HL-1 murine cardiomyocytes. Cell
Mol Biol Lett. 15:551–563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan F, Ma S, Cao W, Liu H, Chen F, Chen X
and Shi R: SDF-1α upregulation of MMP-2 is mediated by p38 MAPK
signaling in pancreatic cancer cell lines. Mol Biol Rep.
40:4139–4146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li YP, Chen Y, John J, Moylan J, Jin B,
Mann DL and Reid MB: TNF-alpha acts via p38 MAPK to stimulate
expression of the ubiquitin ligase atrogin1/MAFbx in skeletal
muscle. FASEB J. 19:362–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stjernberg-Salmela S, Ranki A, Karenko L,
Siitonen S, Mustonen H, Puolakkainen P, Sarna S, Pettersson T and
Repo H: Low TNF-induced NF-kappaB and p38 phosphorylation levels in
leucocytes in tumour necrosis factor receptor-associated periodic
syndrome. Rheumatology (Oxford). 49:382–390. 2010. View Article : Google Scholar
|
|
22
|
Bibikova E, Youn MY, Danilova N, Ono-Uruga
Y, Konto-Ghiorghi Y, Ochoa R, Narla A, Glader B, Lin S and Sakamoto
KM: TNF-mediated inflammation represses GATA1 and activates p38 MAP
kinase in RPS19-deficient hematopoietic progenitors. Blood.
124:3791–3798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wajant H: The role of TNF in cancer.
Results Probl Cell Differ. 49:1–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X and Lin Y: Tumor necrosis factor
and cancer, buddies or foes? Acta Pharmacol Sin. 29:1275–1288.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nabors LB, Suswam E, Huang Y, Yang X,
Johnson MJ and King PH: Tumor necrosis factor alpha induces
angiogenic factor up-regulation in malignant glioma cells: A role
for RNA stabilization and HuR. Cancer Res. 63:4181–4187.
2003.PubMed/NCBI
|
|
26
|
Kulbe H, Thompson R, Wilson JL, Robinson
S, Hagemann T, Fatah R, Gould D, Ayhan A and Balkwill F: The
inflammatory cytokine tumor necrosis factor-alpha generates an
autocrine tumor-promoting network in epithelial ovarian cancer
cells. Cancer Res. 67:585–592. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferrajoli A, Keating MJ, Manshouri T,
Giles FJ, Dey A, Estrov Z, Koller CA, Kurzrock R, Thomas DA, Faderl
S, et al: The clinical significance of tumor necrosis factor-alpha
plasma level in patients having chronic lymphocytic leukemia.
Blood. 100:1215–1219. 2002.PubMed/NCBI
|
|
28
|
Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson
JL, Wilbanks GD, Burke F and Balkwill FR: Expression and regulation
of tumor necrosis factor alpha in normal and malignant ovarian
epithelium. Mol Cancer Ther. 5:382–390. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Michalaki V, Syrigos K, Charles P and
Waxman J: Serum levels of IL-6 and TNF-alpha correlate with
clinicopathological features and patient survival in patients with
prostate cancer. Br J Cancer. 90:2312–2316. 2004.PubMed/NCBI
|
|
30
|
Tomita Y, Yang X, Ishida Y, Nemoto-Sasaki
Y, Kondo T, Oda M, Watanabe G, Chaldakov GN, Fujii C and Mukaida N:
Spontaneous regression of lung metastasis in the absence of tumor
necrosis factor receptor p55. Int J Cancer. 112:927–933. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bates RC and Mercurio AM: Tumor necrosis
factor-alpha stimulates the epithelial-to-mesenchymal transition of
human colonic organoids. Mol Biol Cell. 14:1790–1800. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hagemann T, Robinson SC, Schulz M, Trumper
L, Balkwill FR and Binder C: Enhanced invasiveness of breast cancer
cell lines upon co-cultivation with macrophages is due to TNF-alpha
dependent up-regulation of matrix metalloproteases. Carcinogenesis.
25:1543–1549. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Villeneuve J, Tremblay P and Vallières L:
Tumor necrosis factor reduces brain tumor growth by enhancing
macrophage recruitment and microcyst formation. Cancer Res.
65:3928–3936. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Niforou KM, Anagnostopoulos AK, Vougas K,
Kittas C, Gorgoulis VG and Tsangaris GT: The proteome profile of
the human osteosarcoma U2OS cell line. Cancer Genomics Proteomics.
5:63–78. 2008.PubMed/NCBI
|
|
35
|
Mori T, Sato Y, Miyamoto K, Kobayashi T,
Shimizu T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Tando T, et al:
TNFα promotes osteosarcoma progression by maintaining tumor cells
in an undifferentiated state. Oncogene. 33:4236–4341. 2014.
View Article : Google Scholar
|
|
36
|
Cooney R, Iocono J, Maish G, Smith JS and
Ehrlich P: Tumor necrosis factor mediates impaired wound healing in
chronic abdominal sepsis. J Trauma. 42:415–420. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kitzis V, Engrav LH and Quinn LS:
Transient exposure to tumor necrosis factor-alpha inhibits collagen
accumulation by cultured hypertrophic scar fibroblasts. J Surg Res.
87:134–141. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang YN, Wang F, Zhou W, Wu ZQ and Xing
YQ: TNF-α stimulates MMP-2 and MMP-9 activities in human corneal
epithelial cells via the activation of FAK/ERK signaling.
Ophthalmic Res. 48:165–170. 2012. View Article : Google Scholar
|
|
39
|
Chang H, Peng X, Bai Q, Zhou Y, Yu X,
Zhang Q, Zhu J and Mi M: Ampelopsin suppresses breast
carcinogenesis by inhibiting the mTOR signalling pathway.
Carcinogenesis. 35:1847–1854. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Luo GQ, Zeng S and Liu DY: Inhibitory
effects of ampelopsin on angiogenesis. Zhong Yao Cai. 29:146–150.
2006.In Chinese. PubMed/NCBI
|
